🇺🇸 FDA
Patent

US 8742141

Inhibition and treatment of prostate cancer metastasis

granted A61KA61K31/37A61P

Quick answer

US patent 8742141 (Inhibition and treatment of prostate cancer metastasis) held by Northwestern University expires Mon May 29 2034 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Northwestern University
Grant date
Tue Jun 03 2014 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon May 29 2034 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
16
CPC classes
A61K, A61K31/37, A61P, A61P35/00